Related references
Note: Only part of the references are listed.NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data
Birkir Reynisson et al.
NUCLEIC ACIDS RESEARCH (2020)
Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society-USA Panel
Huldrych F. Gunthard et al.
CLINICAL INFECTIOUS DISEASES (2019)
Bridging the gap between HIV epidemiology and antiretroviral resistance evolution: Modelling the spread of resistance in South Africa
Anthony Hauser et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
Trends in Pretreatment HIV-1 Drug Resistance in Antiretroviral Therapy-naive Adults in South Africa, 2000-2016: A Pooled Sequence Analysis
Benjamin Chimukangara et al.
ECLINICALMEDICINE (2019)
Quantifying the fitness cost of HIV-1 drug resistance mutations through phylodynamics
Denise Kuhnert et al.
PLOS PATHOGENS (2018)
Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors?
K. Kletenkov et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
High prevalence of HIV-1 transmitted drug-resistance mutations from proviral DNA massively parallel sequencing data of therapy-naive chronically infected Brazilian blood donors
Rodrigo Pessoa et al.
PLOS ONE (2017)
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe
L. Marije Hofstra et al.
CLINICAL INFECTIOUS DISEASES (2016)
Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons
L. Ryom et al.
HIV MEDICINE (2016)
Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis
Alexandra U. Scherrer et al.
CLINICAL INFECTIOUS DISEASES (2016)
High-Accuracy HLA Type Inference from Whole-Genome Sequencing Data Using Population Reference Graphs
Alexander T. Dilthey et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
Persistence of Transmitted HIV-1 Drug Resistance Mutations Associated with Fitness Costs and Viral Genetic Backgrounds
Wan-Lin Yang et al.
PLOS PATHOGENS (2015)
OptiType: precision HLA typing from next-generation sequencing data
Andras Szolek et al.
BIOINFORMATICS (2014)
HIV Control Is Mediated in Part by CD8+ T-Cell Targeting of Specific Epitopes
Florencia Pereyra et al.
JOURNAL OF VIROLOGY (2014)
Broad HIV Epitope Specificity and Viral Inhibition Induced by Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults
Jakub Kopycinski et al.
PLOS ONE (2014)
Naturally Selected Rilpivirine-Resistant HIV-1 Variants by Host Cellular Immunity
Hiroyuki Gatanaga et al.
CLINICAL INFECTIOUS DISEASES (2013)
Imputing Amino Acid Polymorphisms in Human Leukocyte Antigens
Xiaoming Jia et al.
PLOS ONE (2013)
Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis
Ravindra K. Gupta et al.
LANCET (2012)
Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients
Avelin F. Aghokeng et al.
AIDS (2011)
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study
Linda Wittkop et al.
LANCET INFECTIOUS DISEASES (2011)
Mapping HIV-1 Vaccine Induced T-Cell Responses: Bias towards Less-Conserved Regions and Potential Impact on Vaccine Efficacy in the Step Study
Fusheng Li et al.
PLOS ONE (2011)
Relative Contribution of HIV-Specific Functional Lymphocyte Subsets Restricted by Protective and Non-Protective HLA Alleles
Yoav Peretz et al.
VIRAL IMMUNOLOGY (2011)
Cohort Profile: The Swiss HIV Cohort Study
Franziska Schoeni-Affolter et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2010)
Additive Contribution of HLA Class I Alleles in the Immune Control of HIV-1 Infection
Alasdair Leslie et al.
JOURNAL OF VIROLOGY (2010)
Prevalence and Clinical Significance of HIV Drug Resistance Mutations by Ultra-Deep Sequencing in Antiretroviral-Naive Subjects in the CASTLE Study
Max Lataillade et al.
PLOS ONE (2010)
The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation
Florencia Pereyra et al.
SCIENCE (2010)
Analysis of the Diversity of the HIV-1 pol Gene and Drug Resistance Associated Changes Among Drug-Naive Patients in Burkina Faso
Denis M. Tebit et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
Selective pressures of HLA genotypes and antiviral therapy on human immunodeficiency virus type 1 sequence mutation at a population level
Golo Ahlenstiel et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination Antiretroviral treatment -: A comparison of different regimen types
Viktor Von Wyl et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Evolution of HIV-1 in an HLA-B*57-positive patient during virologic escape
Justin R. Bailey et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
CD8(+) T-cell responses to different HIV proteins have discordant associations with viral load
Photini Kiepiela et al.
NATURE MEDICINE (2007)
Selection on the human immunodeficiency virus type 1 proteome following primary infection
Yi Liu et al.
JOURNAL OF VIROLOGY (2006)
HIV evolution: CTL escape mutation and reversion after transmission
AJ Leslie et al.
NATURE MEDICINE (2004)
MHC polymorphism under host-pathogen coevolution
JAM Borghans et al.
IMMUNOGENETICS (2004)
Human immunodeficiency virus reverse transcriptase and protease sequence database
SY Rhee et al.
NUCLEIC ACIDS RESEARCH (2003)
An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected thais
KB Bond et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2001)
Share Paper
